Targeting the Microtubular Network as a New Antimyeloma Strategy
Rentian Feng(National Institute for Occupational Safety and Health), Suzanne Lentzsch(UPMC Hillman Cancer Center)
Cited by 28
Related Papers
Inhibition of Activator Protein-1, NF-κB, and MAPKs and Induction of Phase 2 Detoxifying Enzyme Activity by Chlorogenic Acid
|Journal of Biological Chemistry|2005|388
Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease
|Journal of Clinical Investigation|2016|73
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
|Nature Communications|2023|19